-
1
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
Action to Control Cardiovascular Risk in Diabetes Study Group
-
Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
-
(2008)
N Engl J Med
, vol.358
, pp. 2545-2559
-
-
-
2
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa0802987
-
ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572 (Pubitemid 351831357)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
Neal, B.4
Billot, L.5
Woodward, M.6
Marre, M.7
Cooper, M.8
Glasziou, P.9
Grobbee, D.10
Hamet, P.11
Harrap, S.12
Heller, S.13
Liu, L.14
Mancia, G.15
Mogensen, C.E.16
Pan, C.17
Poulter, N.18
Rodgers, A.19
Williams, B.20
Bompoint, S.21
De Galan, B.E.22
Joshi, R.23
Travert, F.24
more..
-
3
-
-
58149389215
-
Glucose control and vascular complications in veterans with type 2 diabetes
-
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven P, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2008;360:129-139
-
(2008)
N Engl J Med
, vol.360
, pp. 129-139
-
-
Duckworth, W.1
Abraira, C.2
Moritz, T.3
Reda, D.4
Emanuele, N.5
Reaven, P.6
-
4
-
-
53749096863
-
10-Year follow up of intensive glucose control in type 2 diabetes
-
Holman R, Paul S, Bethel MA, Matthews D, Neil A. 10-year follow up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
-
(2008)
N Engl J Med
, vol.359
, pp. 1577-1589
-
-
Holman, R.1
Paul, S.2
Bethel, M.A.3
Matthews, D.4
Neil, A.5
-
5
-
-
0014914649
-
A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes, II mortality results
-
Meinert C, Knatterud G, Prout T, Klimt C. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes, II mortality results. Diabetes 1970;19(suppl):789-830.
-
(1970)
Diabetes
, vol.19
, Issue.SUPPL.
, pp. 789-830
-
-
Meinert, C.1
Knatterud, G.2
Prout, T.3
Klimt, C.4
-
6
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
7
-
-
0034709738
-
Seeing what you want to see in randomised controlled trials: Versions and perversions of UKPDS data
-
McCormack J, Greenhalgh T. Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. BMJ 2000;320:1720-1723 (Pubitemid 30410489)
-
(2000)
British Medical Journal
, vol.320
, Issue.7251
, pp. 1720-1723
-
-
McCormack, J.1
Greenhalgh, T.2
-
8
-
-
58849139160
-
The ACCORD trial and control of blood glucose level in type 2 diabetes mellitus
-
Havas S. The ACCORD trial and control of blood glucose level in type 2 diabetes mellitus. Arch Intern Med 2009;169:150-154
-
(2009)
Arch Intern Med
, vol.169
, pp. 150-154
-
-
Havas, S.1
-
9
-
-
54949090768
-
Cardiovascular outcomes in trials of oral diabetes medications
-
Selvin E, Bolen S, Yeh H-C, Wiley C, Wilson L, Marinopoulos S, et al. Cardiovascular outcomes in trials of oral diabetes medications. Arch Intern Med 2008;168:2070.
-
(2008)
Arch Intern Med
, vol.168
, pp. 2070
-
-
Selvin, E.1
Bolen, S.2
Yeh, H.-C.3
Wiley, C.4
Wilson, L.5
Marinopoulos, S.6
|